183 related articles for article (PubMed ID: 32258098)
1. STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial-Mesenchymal Transition.
Lin C; Sun L; Huang S; Weng X; Wu Z
Biomed Res Int; 2019; 2019():8042489. PubMed ID: 32258098
[TBL] [Abstract][Full Text] [Related]
2. STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer.
Wu J; Lai M; Shao C; Wang J; Wei JJ
Oncol Rep; 2015 Sep; 34(3):1494-502. PubMed ID: 26165228
[TBL] [Abstract][Full Text] [Related]
3. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells.
Law AY; Wong CK
Exp Cell Res; 2010 Dec; 316(20):3425-34. PubMed ID: 20619259
[TBL] [Abstract][Full Text] [Related]
4. Effect of STC2 gene silencing on colorectal cancer cells.
Li Q; Zhou X; Fang Z; Pan Z
Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
[TBL] [Abstract][Full Text] [Related]
5. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma.
Li JB; Liu ZX; Zhang R; Ma SP; Lin T; Li YX; Yang SH; Zhang WC; Wang YP
World J Gastroenterol; 2019 Jun; 25(22):2776-2787. PubMed ID: 31236000
[TBL] [Abstract][Full Text] [Related]
6. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
Na SS; Aldonza MB; Sung HJ; Kim YI; Son YS; Cho S; Cho JY
Biochim Biophys Acta; 2015 Jun; 1854(6):668-76. PubMed ID: 25463045
[TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma.
Ferreira do Carmo A; Dourado MR; Ervolino de Oliveira C; Bastos DC; Domingueti CB; Ribeiro Paranaíba LM; Sawazaki-Calone Í; Borges GÁ; Silva Guerra EN; Casarin RC; Graner E; Salo TA; de Almeida Freitas R; Galvão HC; Coletta RD
Exp Cell Res; 2020 Aug; 393(2):112092. PubMed ID: 32445747
[TBL] [Abstract][Full Text] [Related]
9. Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma.
Li J; Zhang Z; Feng X; Shen Z; Sun J; Zhang X; Bu F; Xu M; Tan C; Wang Z
Cell Biol Toxicol; 2022 Apr; 38(2):259-272. PubMed ID: 33797657
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Yanagita S; Hagihara T; Haraguchi N; Matsushita D; Hirahara T; Okumura H; Uchikado Y; Nakajo A; Hokita S; Natsugoe S
Oncol Rep; 2013 Dec; 30(6):2838-44. PubMed ID: 24100594
[TBL] [Abstract][Full Text] [Related]
11. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
[TBL] [Abstract][Full Text] [Related]
12. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
[TBL] [Abstract][Full Text] [Related]
15. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.
Qie S; Sang N
J Exp Clin Cancer Res; 2022 May; 41(1):161. PubMed ID: 35501821
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Gremlin 1 by sonic hedgehog signaling promotes pancreatic cancer progression.
Yu Y; Cheng L; Yan B; Zhou C; Qian W; Xiao Y; Qin T; Cao J; Han L; Ma Q; Ma J
Int J Oncol; 2018 Dec; 53(6):2445-2457. PubMed ID: 30272371
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
[TBL] [Abstract][Full Text] [Related]
18. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia.
Law AY; Wong CK
Exp Cell Res; 2010 Feb; 316(3):466-76. PubMed ID: 19786016
[TBL] [Abstract][Full Text] [Related]
19. Stanniocalicin 2 suppresses breast cancer cell migration and invasion via the PKC/claudin-1-mediated signaling.
Hou J; Wang Z; Xu H; Yang L; Yu X; Yang Z; Deng Y; Meng J; Feng Y; Guo X; Yang G
PLoS One; 2015; 10(4):e0122179. PubMed ID: 25830567
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
